ArticlePloS one2016

A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation.

Thomas Hills et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.